Reproductive Outcome in Assisted Conception Cycles

Assiut University

Status: Completed

Conditions: Infertility

Treatments: Radiation: Basal antral follicle count; Diagnostic Test: Anti-mullerian hormone; Diagnostic Test: follicular stimulating hormone

Study type: Interventional

Funder types: Other

Identifiers

NCT03846388

ACC

Details and patient eligibility

About

Infertility is the failure to conceive after regular unprotected sexual intercourse for one year. Primary infertility refers woman who has never conceived, and secondary infertility to one who has had a previous pregnancy.The most frequent causes for infertility are ovulatory disorder or anovulation (27-30%) , tubal factor(20-22%), abnormal semen parameters(45-50%). Unexplained infertility refers to infertile couples in whom standard investigations, including tests of ovulation, tubal patency tests and semen analysis are normal. incidence 15-17% of infertile couples. New guidelines on infertility recommend that women with unexplained infertility should be advised for expectant management for 2 years .If pregnancy is not achieved after this period In vitro fertilization Should be considered. The Fast Track and Standard Treatment trial demonstrated A shorter time to pregnancy and higher per cycle pregnancy rates for In vitro fertilization compared with treatment with oral agents or gonadotropins in Patients with unexplained infertility. Successful pregnancy after assisted reproductive technology is influenced by numerous predictors that have been investigated in the previous years. The central predictors of success are the sperm, oocyte quality and endometrial receptivity. Oocyte quality depends mainly on the age of the woman , and her ovarian reserve. Parameters most commonly studied are the woman's age , her antral follicle count , and laboratory tests including serum randomly done during the menstrual cycle levels at day 3 of the cycle.

Enrollment: 292 patients

Sex: Female

Ages: 20 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• in vitro fertilization treatment due to many factors including tubal, male, and unexplained factors.
• body mass index (BMI) (18-35)kg/m2

Exclusion Criteria

1. patient age less than 20 and more than 40 years.
2. body mass index less than 18 and more than 35 kg/m2.
3. period of infertility less than 2 years..
4. untreated hyperthyroidism, hypothyroidism, diabetes, hypertension.

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

292 participants in 2 patient groups

Patients with unexplained infertility

Other group

Treatment:

Diagnostic Test: follicular stimulating hormone

Diagnostic Test: Anti-mullerian hormone

Radiation: Basal antral follicle count

patients with tubal, male factor or polycystic ovary syndrome

Other group

Treatment:

Diagnostic Test: follicular stimulating hormone

Diagnostic Test: Anti-mullerian hormone

Radiation: Basal antral follicle count